Pulmonary CCL18 recruits human regulatory T cells

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 128-137

  Chenivesse, Cécile ^a,b,c   Chang, Ying ^a,b,c   Azzaoui, Imane ^a,b,c   Yahia, Saliha Ait ^a,b,c   Morales, Olivier ^d   Plé, Coline ^a,b,c   Foussat, Arnaud ^e   Tonnel, André Bernard ^a,b,c   Delhem, Nadira ^d   Yssel, Hans ^f   Vorng, Han ^a,b,c   Wallaert, Benoit ^a,b,c   Tsicopoulos, Anne ^a,b,c  

^a INSERM   (France)

^b INSERM U1019   (France)

^c UNIV LILLE   (France)

^d CNRS   (France)

^e Txcell   (France)

^f Institut de la Santé et de la Recherche Médicale Unité 844   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CCL18 CHEMOKINE; CD4 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 7 RECEPTOR; LATENCY ASSOCIATED PEPTIDE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ CD25- T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SURFACE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE CLONE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; CLONE CELLS; HUMANS; INTERLEUKIN-10; LUNG; MICE; MICE, SCID; SKIN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY;

EID: 84862861762     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003616     Document Type: Article

References (60)

1. Zheng, Y., and A. Y. Rudensky. 2007. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8: 457-462. (Pubitemid 46605910)
2. Sakaguchi, S., M. Toda, M. Asano, M. Itoh, S. S. Morse, and N. Sakaguchi. 1996. T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases. J. Autoimmun. 9: 211-220. (Pubitemid 26163865)
3. Read, S., V. Malmström, and F. Powrie. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302. (Pubitemid 30470312)
4. Izcue, A., J. L. Coombes, and F. Powrie. 2006. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212: 256-271. (Pubitemid 44116713)
5. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338-344.
6. Weaver, C. T., L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688. (Pubitemid 43867371)
7. Roncarolo, M. G., S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M. K. Levings. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212: 28-50. (Pubitemid 44116698)
8. Bromley, S. K., T. R. Mempel, and A. D. Luster. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9: 970-980.
9. Soler, D., T. R. Chapman, L. R. Poisson, L. Wang, J. Cote-Sierra, M. Ryan, A. McDonald, S. Badola, E. Fedyk, A. J. Coyle, et al. 2006. CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J. Immunol. 177: 6940-6951. (Pubitemid 44715060)
10. Sebastiani, S., P. Allavena, C. Albanesi, F. Nasorri, G. Bianchi, C. Traidl, S. Sozzani, G. Girolomoni, and A. Cavani. 2001. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J. Immunol. 166: 996-1002. (Pubitemid 32060256)
11. Colantonio, L., A. Iellem, F. Sinigaglia, and D. D'Ambrosio. 2002. Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur. J. Immunol. 32: 3506-3514. (Pubitemid 36024387)
12. Iellem, A., M. Mariani, R. Lang, H. Recalde, P. Panina-Bordignon, F. Sinigaglia, and D. D'Ambrosio. 2001. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 194: 847-853. (Pubitemid 32983019)
13. Schutyser, E., S. Struyf, A.Wuyts,W. Put, K. Geboes, B. Grillet, G. Opdenakker, and J. Van Damme. 2001. Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis. Eur. J. Immunol. 31: 3755-3762. (Pubitemid 34030989)
14. de Nadaï, P., A. S. Charbonnier, C. Chenivesse, S. Sénéchal, C. Fournier, J. Gilet, H. Vorng, Y. Chang, P. Gosset, B. Wallaert, et al. 2006. Involvement of CCL18 in allergic asthma. J. Immunol. 176: 6286-6293.
15. Kodelja, V., C. Müller, O. Politz, N. Hakij, C. E. Orfanos, and S. Goerdt. 1998. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J. Immunol. 160: 1411-1418. (Pubitemid 28093442)
16. Schutyser, E., A. Richmond, and J. Van Damme. 2005. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. J. Leukoc. Biol. 78: 14-26. (Pubitemid 40979939)
17. Tasaki, Y., S. Fukuda, M. Iio, R. Miura, T. Imai, S. Sugano, O. Yoshie, A. L. Hughes, and H. Nomiyama. 1999. Chemokine PARC gene (SCYA18) generated by fusion of two MIP-1alpha/LD78alpha-like genes. Genomics 55: 353-357.
18. Schraufstatter, I., H. Takamori, L. Sikora, P. Sriramarao, and R. G. DiScipio. 2004. Eosinophils and monocytes produce pulmonary and activation-regulated chemokine, which activates cultured monocytes/macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L494-L501. (Pubitemid 38233619)
19. Hieshima, K., T. Imai, M. Baba, K. Shoudai, K. Ishizuka, T. Nakagawa, J. Tsuruta, M. Takeya, Y. Sakaki, K. Takatsuki, et al. 1997. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J. Immunol. 159: 1140-1149. (Pubitemid 127484089)
20. Adema, G. J., F. Hartgers, R. Verstraten, E. de Vries, G. Marland, S. Menon, J. Foster, Y. Xu, P. Nooyen, T. McClanahan, et al. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387: 713-717. (Pubitemid 27270612)
21. Vulcano, M., S. Struyf, P. Scapini, M. Cassatella, S. Bernasconi, R. Bonecchi, A. Calleri, G. Penna, L. Adorini, W. Luini, et al. 2003. Unique regulation of CCL18 production by maturing dendritic cells. J. Immunol. 170: 3843-3849. (Pubitemid 36359255)
22. Chang, Y., P. de Nadai, I. Azzaoui, O. Morales, N. Delhem, H. Vorng, S. Tomavo, S. Ait Yahia, G. Zhang, B. Wallaert, et al. 2010. The chemokine CCL18 generates adaptive regulatory T cells from memory CD4+ T cells of healthy but not allergic subjects. FASEB J. 24: 5063-5072.
23. Azzaoui, I., S. A. Yahia, Y. Chang, H. Vorng, O. Morales, Y. Fan, N. Delhem, C. Ple, A. B. Tonnel, B. Wallaert, and A. Tsicopoulos. 2011. CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects. Blood 118: 3549-3558.
24. Lécart, S., V. Boulay, N. Raison-Peyron, J. Bousquet, L. Meunier, H. Yssel, and J. Pène. 2001. Phenotypic characterization of human CD4+ regulatory T cells obtained from cutaneous dinitrochlorobenzene-induced delayed type hypersensitivity reactions. J. Invest. Dermatol. 117: 318-325. (Pubitemid 34205717)
25. Brun, V., H. Bastian, V. Neveu, and A. Foussat. 2009. Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases. Int. Immunopharmacol. 9: 609-613.
26. Chang, Y., S. Sénéchal, P. de Nadai, C. Chenivesse, J. Gilet, H. Vorng, B. Legendre, A. B. Tonnel, B. Wallaert, P. Lassalle, and A. Tsicopoulos. 2006. Diesel exhaust exposure favors TH2 cell recruitment in nonatopic subjects by differentially regulating chemokine production. J. Allergy Clin. Immunol. 118: 354-360. (Pubitemid 44160718)
27. Gilet, J., Y. Chang, C. Chenivesse, B. Legendre, H. Vorng, C. Duez, B. Wallaert, H. Porte, S. Senechal, and A. Tsicopoulos. 2009. Role of CCL17 in the generation of cutaneous inflammatory reactions in Hu-PBMC-SCID mice grafted with human skin. J. Invest. Dermatol. 129: 879-890.
28. Callebaut, I., K. Prat, E. Meurice, J. P. Mornon, and S. Tomavo. 2005. Prediction of the general transcription factors associated with RNA polymerase II in Plasmodium falciparum: conserved features and differences relative to other eukaryotes. BMC Genomics 6: 100.
29. Sénéchal, S., O. Fahy, T. Gentina, H. Vorng, M. Capron, A. F. Walls, A. R. McEuen, M. G. Buckley, Q. Hamid, B. Wallaert, et al. 2002. CCR3-blocking antibody inhibits allergen-induced eosinophil recruitment in human skin xenografts from allergic patients. Lab. Invest. 82: 929-939. (Pubitemid 34761668)
30. de Nadaï, P., C. Chenivesse, J. Gilet, H. Porte, H. Vorng, Y. Chang, A. F. Walls, B. Wallaert, A. B. Tonnel, A. Tsicopoulos, and H. G. Zerwes. 2006. CCR5 usage by CCL5 induces a selective leukocyte recruitment in human skin xenografts in vivo. J. Invest. Dermatol. 126: 2057-2064.
31. Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203: 1693-1700. (Pubitemid 44036275)
32. Kemper, C., A. C. Chan, J. M. Green, K. A. Brett, K. M. Murphy, and J. P. Atkinson. 2003. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421: 388-392. (Pubitemid 36157938)
33. Fritzsching, B., N. Oberle, E. Pauly, R. Geffers, J. Buer, J. Poschl, P. Krammer, O. Linderkamp, and E. Suri-Payer. 2006. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 108: 3371-3378.
34. Baecher-Allan, C., J. A. Brown, G. J. Freeman, and D. A. Hafler. 2001. CD4+ CD25high regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253. (Pubitemid 32703119)
35. Nakamura, K., A. Kitani, I. Fuss, A. Pedersen, N. Harada, H. Nawata, and W. Strober. 2004. TGF-beta 1 plays an important role in the mechanism of CD4+ CD25+ regulatory T cell activity in both humans and mice. J. Immunol. 172: 834-842. (Pubitemid 38113739)
36. Allakhverdi, Z., D. Fitzpatrick, A. Boisvert, N. Baba, S. Bouguermouh, M. Sarfati, and G. Delespesse. 2006. Expression of CD103 identifies human regulatory T-cell subsets. J. Allergy Clin. Immunol. 118: 1342-1349. (Pubitemid 44854109)
37. Birebent, B., R. Lorho, H. Lechartier, S. de Guibert, M. Alizadeh, N. Vu, A. Beauplet, N. Robillard, and G. Semana. 2004. Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression. Eur. J. Immunol. 34: 3485-3496. (Pubitemid 40012166)
38. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787. (Pubitemid 351707693)
39. Proudfoot, A. E. I., T. M. Handel, Z. Johnson, E. K. Lau, P. LiWang, I. Clark-Lewis, F. Borlat, T. N. Wells, and M. H. Kosco-Vilbois. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100: 1885-1890. (Pubitemid 36254543)
40. Jordan, M. S., A. Boesteanu, A. J. Reed, A. L. Petrone, A. E. Holenbeck, M. A. Lerman, A. Naji, and A. J. Caton. 2001. Thymic selection of CD4+CD25 + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306. (Pubitemid 33706340)
41. Apostolou, I., A. Sarukhan, L. Klein, and H. von Boehmer. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3: 756-763.
42. Groux, H., A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J. E. de Vries, and M. G. Roncarolo. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742. (Pubitemid 27458961)
43. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617. (Pubitemid 36588578)
44. Grossman, W. J., J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson, and T. J. Ley. 2004. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21: 589-601. (Pubitemid 39370513)
45. Han, Y., Q. Guo, M. Zhang, Z. Chen, and X. Cao. 2009. CD69+ CD4+ CD25-T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J. Immunol. 182: 111-120.
46. Chen, M. L., B. S. Yan, Y. Bando, V. K. Kuchroo, and H. L. Weiner. 2008. Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis. J. Immunol. 180: 7327-7337.
47. Tran, D. Q., J. Andersson, D. Hardwick, L. Bebris, G. G. Illei, and E. M. Shevach. 2009. Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 113: 5125-5133.
48. Andersson, J., D. Q. Tran, M. Pesu, T. S. Davidson, H. Ramsey, J. J. O'Shea, and E. M. Shevach. 2008. CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J. Exp. Med. 205: 1975-1981.
49. Gandhi, R., M. F. Farez, Y. Wang, D. Kozoriz, F. J. Quintana, and H. L. Weiner. 2010. Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset. J. Immunol. 184: 4620-4624.
50. Huehn, J., and A. Hamann. 2005. Homing to suppress: address codes for Treg migration. Trends Immunol. 26: 632-636. (Pubitemid 41628195)
51. Wei, S., I. Kryczek, and W. Zou. 2006. Regulatory T-cell compartmentalization and trafficking. Blood 108: 426-431. (Pubitemid 44061338)
52. Baatar, D., P. Olkhanud, K. Sumitomo, D. Taub, R. Gress, and A. Biragyn. 2007. Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL. J. Immunol. 178: 4891-4900. (Pubitemid 46595271)
53. Mikhak, Z., M. Fukui, A. Farsidjani, B. D. Medoff, A. M. Tager, and A. D. Luster. 2009. Contribution of CCR4 and CCR8 to antigen-specific T(H)2 cell trafficking in allergic pulmonary inflammation. J. Allergy Clin. Immunol. 123: 67-73.e3.
54. Sather, B. D., P. Treuting, N. Perdue, M. Miazgowicz, J. D. Fontenot, A. Y. Rudensky, and D. J. Campbell. 2007. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204: 1335-1347. (Pubitemid 46919872)
55. Tiemessen, M. M., A. L. Jagger, H. G. Evans, M. J. C. van Herwijnen, S. John, and L. S. Taams. 2007. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. USA 104: 19446-19451.
56. Günther, C., C. Bello-Fernandez, T. Kopp, J. Kund, N. Carballido-Perrig, S. Hinteregger, S. Fassl, C. Schwärzler, G. Lametschwandtner, G. Stingl, et al. 2005. CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J. Immunol. 174: 1723-1728.
57. El-Asrar, A. M. A., S. Struyf, S. A. Al-Kharashi, L. Missotten, J. Van Damme, and K. Geboes. 2002. Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis. Br. J. Ophthalmol. 86: 1175-1180.
58. Umetsu, D. T., J. J. McIntire, O. Akbari, C. Macaubas, and R. H. DeKruyff. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3: 715-720.
59. Kim, B. S., I. K. Kim, Y. J. Park, Y. S. Kim, Y. J. Kim, W. S. Chang, Y. S. Lee, M. N. Kweon, Y. Chung, and C. Y. Kang. 2010. Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing Th2-mediated allergic asthma. Proc. Natl. Acad. Sci. USA 107: 8742-8747.
60. Curotto de Lafaille, M. A., N. Kutchukhidze, S. Shen, Y. Ding, H. Yee, and J. J. Lafaille. 2008. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29: 114-126.